Aquatic Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Aquatic Capital Management’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$579K	Buy	+23,863	New	+$406K	0.02%	744
2026 Q1	–	Sell	-36,820	Closed	-$698K	–	1681
2025 Q4	$698K	Buy	+36,820	New	+$529K	0.02%	643
2025 Q1	–	Sell	-4,610	Closed	-$86.9K	–	1521
2024 Q4	$86.9K	Buy	+4,610	New	+$106K	﹤0.01%	1090
2023 Q4	–	Sell	-1,800	Closed	-$14K	–	1536
2023 Q3	$14K	Buy	+1,800	New	+$16.4K	﹤0.01%	1104
2023 Q2	–	Sell	-1,100	Closed	-$10K	–	1623
2023 Q1	$10K	Buy	+1,100	New	+$11.5K	﹤0.01%	1122

Other funds holding NRIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aquatic Capital Management's NRIX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 23,863 shares worth $579K. The stake represents 0.02% of the portfolio and ranks #744 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in NRIX as recently as Q4 2025.

Aquatic Capital Management first reported a position in NRIX in Q1 2023 and has held it in 5 quarters since. The position peaked at $698K in Q4 2025. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

Aquatic Capital Management held 23,863 shares of Nurix Therapeutics worth $579K as of Q2 2026.
Nurix Therapeutics was a new Aquatic Capital Management position in Q2 2026.
Nurix Therapeutics made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #744 holding.
Aquatic Capital Management first reported a position in Nurix Therapeutics in Q1 2023 and has held it in 5 quarters since.
Aquatic Capital Management's Nurix Therapeutics position peaked at $698K in Q4 2025.
211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.